OptimizeRx Corp. (OPRX)

Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook

Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON)

OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

AWM Investment Company Inc. Invests $1.38 Million in OptimizeRx Corp. $OPRX

Dimensional Fund Advisors LP Purchases 102,661 Shares of OptimizeRx Corp. $OPRX

OptimizeRx Q2 Earnings Call Highlights

OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript

OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer